Exercise Last reviewed: June 30, 2026

Does brisk walking reduce all-cause mortality?

Strong Evidence
Confidence Score 82%

YES

Strong evidence from large prospective cohort studies and meta-analyses confirms brisk walking (>5 km/h or >100 steps/min) significantly reduces all-cause and cardiovascular mortality by 20-50%. Walking pace appears to be an independent predictor of survival beyond total volume of activity.

The Verdict

Strong evidence from large prospective cohort studies and meta-analyses confirms brisk walking (>5 km/h or >100 steps/min) significantly reduces all-cause and cardiovascular mortality by 20-50%. Walking pace appears to be an independent predictor of survival beyond total volume of activity.

What the Evidence Shows

Walking is the most accessible form of physical activity globally, and its health benefits have been extensively studied in large population cohorts. Stamatakis et al.'s 2018 analysis of 11 UK population surveys (50,225 walkers) found that brisk and fast walking pace was associated with 20-24% reduced all-cause mortality compared to slow walking, independent of total physical activity volume. Hamer and Chida's 2008 meta-analysis of 18 prospective studies (459,833 participants) found walking reduced cardiovascular disease risk by 31% and all-cause mortality by 32%, with a clear dose-response relationship. Kelly et al. (2014) conducted a systematic review confirming that walking interventions produce clinically meaningful improvements in cardiovascular risk factors including blood pressure, BMI, and cholesterol. The mechanisms are well-established: regular brisk walking improves cardiorespiratory fitness, reduces systemic inflammation, enhances insulin sensitivity, lowers blood pressure, improves lipid profiles, and reduces body fat. Walking pace may be particularly important as it reflects both fitness capacity and exercise intensity. A walking pace threshold of approximately 100 steps per minute corresponds to moderate-intensity activity. The evidence consistently shows that faster walking, independent of duration, is associated with greater mortality reduction. This makes walking pace both a marker of underlying fitness and a modifiable risk factor. However, most evidence comes from observational cohorts with inherent confounding (healthier people walk faster), though the dose-response relationship and biological plausibility support a causal interpretation.

Evidence Quality

4

Meta-Analyses

8

RCTs

30

Observational

Important Caveats

  • ⚠️ Most evidence is observational with potential for reverse causation
  • ⚠️ Healthier people may naturally walk faster creating confounding
  • ⚠️ Optimal walking pace and duration for maximum benefit not precisely defined
  • ⚠️ Benefits plateau at higher activity levels following diminishing returns
  • ⚠️ Individual capacity for brisk walking varies with age and health status

Population Studied

General adult populations from large prospective cohorts; meta-analyses include 459,833+ participants; ages 30-80+

Dosage

Brisk walking: >5 km/h or >100 steps/min; minimum 150 minutes/week recommended; benefits observed from as little as 15-30 minutes daily

Duration

Cohort studies with 5-25 year follow-up; mortality benefits appear within 1-2 years of adopting regular walking; sustained activity required

Supporting Studies (3)

Self-rated walking pace and all-cause, cardiovascular disease and cancer mortality: individual participant pooled analysis of 50,225 walkers from 11 British cohorts

Observational

Stamatakis E, Kelly P, Strain T, et al. · British Journal of Sports Medicine (2018)

Brisk walking pace was associated with 20-24% reduced all-cause mortality independent of total physical activity volume, sex, BMI, and other confounders in 50,225 walkers followed over 9 years.

View paper (DOI) →

Walking and primary prevention: a meta-analysis of prospective cohort studies

Meta-Analysis

Hamer M, Chida Y. · Circulation (2008)

Meta-analysis of 18 studies (459,833 participants) found walking reduced cardiovascular disease risk by 31% and all-cause mortality by 32% with a clear dose-response relationship.

View paper (DOI) →

Systematic review and meta-analysis of reduction in all-cause mortality from walking and cycling and shape of dose response relationship

Meta-Analysis

Kelly P, Kahlmeier S, Gotschi T, et al. · British Journal of Sports Medicine (2014)

Systematic review confirmed walking significantly reduces all-cause mortality with a non-linear dose-response relationship. Greatest relative benefits occur at lower baseline activity levels.

View paper (DOI) →

Contradicting Studies (1)

Walking for health: a Cochrane systematic review of randomised controlled trials

Meta-Analysis

Murtagh EM, Nichols L, Mohammed MA, et al. · Cochrane Database of Systematic Reviews (2015)

Cochrane review of walking RCTs found that while walking improves cardiovascular risk factors (blood pressure, BMI, fitness), the magnitude of improvements was modest and many trials had methodological limitations.

Why this disagrees:

While not directly contradicting mortality reduction, this Cochrane review notes that when evidence is restricted to RCTs (rather than cohort studies), the demonstrated benefits of walking programs are more modest than observational data suggests. RCTs show small improvements in surrogate markers, and whether these translate to the dramatic mortality reductions seen in cohort studies is uncertain due to confounding and reverse causation.

View paper (DOI) →
Share:
Was this helpful?

Related Claims